So the thing is, the recent CGS classification, which is the IMS-IMWG classification, integrates NGS at diagnosis. But as you say, it’s not possible everywhere. The standard FISH, when it comes to cost, is now becoming comparable to NGS, so I would recommend and urge all reference centers to collaborate with community doctors for such tests, and that will not only make the patients get access to such very important data, but also make the tests become even cheaper...
So the thing is, the recent CGS classification, which is the IMS-IMWG classification, integrates NGS at diagnosis. But as you say, it’s not possible everywhere. The standard FISH, when it comes to cost, is now becoming comparable to NGS, so I would recommend and urge all reference centers to collaborate with community doctors for such tests, and that will not only make the patients get access to such very important data, but also make the tests become even cheaper. So with the newer NGS techniques, now it’s not only the prognostic determination, but also to check for at relapse mainly for mutations which are very relevant to immunotherapies. So these are all together in one package, which is really very helpful in designing the next treatment. So it’s a step towards personalization or individualization of treatment.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.